An interleukin-33/ST2 signaling deficiency reduces overt pain-like behaviors in mice

Brazilian Journal of Medical and Biological Research

Volumn 46, Issue 7, 2013, Pages 601-606

  Magro, D A C ^a   Hohmann, M S N ^b   Mizokami, S S ^b   Cunha, T M ^a   Alves Filho, J C ^a   Casagrande, R ^b   Ferreira, S H ^a   Liew, F Y ^c   Cunha, F Q ^a   Verri, Jr ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Inflammation; Interleukin 33; Nociception; Pain; ST2

Indexed keywords

CYTOKINE; INTERLEUKIN 33; INTERLEUKIN ST2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; HOT PLATE TEST; IMMUNIZATION; LICKING; MOTOR COORDINATION; MOUSE; NOCICEPTION; NONHUMAN; PAIN; SIGNAL TRANSDUCTION; WRITHING TEST;

MUS;

ACETIC ACID; ANIMALS; BENZOQUINONES; HOMOZYGOTE; HOT TEMPERATURE; HYPERALGESIA; INTERLEUKINS; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; NOCICEPTION; NOCICEPTIVE PAIN; OVALBUMIN; PAIN MEASUREMENT; RECEPTORS, INTERLEUKIN; ROTAROD PERFORMANCE TEST; SIGNAL TRANSDUCTION;

EID: 84881602946     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20132894     Document Type: Article

References (20)

1. Pavao-de-Souza GF, Zarpelon AC, Tedeschi GC, Mizokami SS, Sanson JS, Cunha TM, et al. Acetic acid-and phenyl-p-benzoquinone-induced overt pain-like behavior depends on spinal activation of MAP kinases, PI(3)K and microglia in mice. Pharmacol Biochem Behav 2012; 101: 320-328.doi: 10.1016/j.pbb.2012.01.018
2. Verri WA Jr, Cunha TM, Magro DA, Domingues AC, Vieira SM, Souza GR, et al. Role of IL-18 in overt pain-like behaviour in mice. Eur J Pharmacol 2008; 588: 207-212.doi: 10.1016/j.ejphar.2008.04.010
3. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977; 4: 161-174.doi: 10.1016/0304-3959(77)90130-0
4. Piovezan AP, Orleans-Juste P, Frighetto M, Souza GE, Henriques MG, Rae GA. Endothelins contribute towards nociception induced by antigen in ovalbumin-sensitised mice. Br J Pharmacol 2004; 141: 755-763.doi: 10.1038/sj.bjp.0705663
5. Ribeiro RA, Vale ML, Thomazzi SM, Paschoalato AB, Poole S, Ferreira SH, et al. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 2000; 387: 111-118.doi: 10.1016/S0014-2999(99)00790-6
6. Mizokami SS, Arakawa NS, Ambrosio SR, Zarpelon AC, Casagrande R, Cunha TM, et al. Kaurenoic acid from Sphagneticola trilobata inhibits inflammatory pain: effect on cytokine production and activation of the NO-cyclic GMP-protein kinase G-ATP-sensitive potassium channel signaling pathway. J Nat Prod 2012; 75: 896-904.doi: 10.1021/np200989t
7. Chichorro JG, Lorenzetti BB, Zampronio AR. Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats. Br J Pharmacol 2004; 141: 1175-1184.doi: 10.1038/sj.bjp.0705724
8. Parada CA, Tambeli CH, Cunha FQ, Ferreira SH. The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience 2001; 102: 937-944.doi: 10.1016/S0306-4522(00)00523-6
9. Puig S, Sorkin LS. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain 1996; 64: 345-355.doi: 10.1016/0304-3959(95)00121-2
10. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479-490.doi: 10.1016/j.immuni.2005.09.015
11. Liew FY, Pitman NI, Mclnnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010; 10: 103-110.doi: 10.1038/nri2692
12. Verri WA Jr, Guerrero AT, Fukada SY, Valerio DA, Cunha TM, Xu D, et al. IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc Natl Acad Sci U SA 2008; 105: 2723-2728.doi: 10.1073/pnas.0712116105
13. Zarpelon A, Cunha T, Alves-Filho J, Pinto L, Ferreira S, McInnes I, et al. IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2. BrJ Pharmacol2013; 169: 90-101.doi: 10.1111/bph.12110
14. Brint EK, Xu D, Liu H, Dunne A, McKenzie AN, O'Neill LA, et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 2004; 5: 373-379.doi: 10.1038/ni1050
15. Verri WA Jr, Souto FO, Vieira SM, Almeida SC, Fukada SY, Xu D, etal. IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann Rheum Dis 2010; 69: 1697-1703.doi: 10.1136/ard.2009.122655
16. Santulli P, Borghese B, Chouzenoux S, Vaiman D, Borderie D, Streuli I, etal. Serum and peritoneal interleukin-33 levels are elevated in deeply infiltrating endometriosis. Hum Reprod 2012; 27: 2001-2009.doi: 10.1093/humrep/des154
17. Han P, Zhao J, Liu SB, Yang CJ, Wang YQ, Wu GC, et al. Interleukin-33 mediates formalin-induced inflammatory pain in mice. Neuroscience 2013; 241: 59-66.doi: 10.1016/j.neuroscience.2013.03.019.
18. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 2008; 3: e3331.doi: 10.1371/journal.pone.0003331
19. Balato A, Lembo S, Mattii M, Schiattarella M, Marino R, De Paulis A, et al. IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation. Exp Dermatol 2012; 21: 892-894.doi: 10.1111/exd.12027
20. Jiang HR, Milovanovic M, Allan D, Niedbala W, Besnard AG, Fukada SY, et al. IL-33 attenuates EAE by suppressing IL-17 and IFN-gamma production and inducing alternatively activated macrophages. Eur J Immunol 2012; 42: 1804-1814.doi: 10.1002/eji.201141947